Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer

NCT07403916 is registered in ClinicalTrials.gov with P. Herzen Moscow Oncology Research Institute as lead sponsor.

NCT NCT07403916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07403916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer
Lead sponsor
P. Herzen Moscow Oncology Research Institute
Phase
Observational
Overall status
Active, not recruiting
Start date
January 10, 2020
Completion date
June 1, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (gc), molecular analysis, next-generation sequencing